Macrophages in Septic Cardiomyopathy: Heterogeneity, Function, and Therapy

Area of Science:

• Immunology
• Cardiology
• Pathophysiology

Background:

• Sepsis triggers a dysregulated immune response, leading to organ dysfunction.
• Septic cardiomyopathy (SCM) is a severe complication, significantly increasing mortality in sepsis patients.
• Macrophages are crucial innate immune cells in the heart, with diverse subsets influencing SCM.

Purpose of the Study:

• To review the heterogeneity of macrophage subsets in sepsis.
• To elucidate their cardiac implications and underlying molecular mechanisms in SCM.
• To provide a foundation for targeted immunomodulatory therapies for SCM.

Main Methods:

• Literature review focusing on macrophage subsets in sepsis and SCM.
• Analysis of molecular mechanisms of macrophage-mediated cardiac injury and protection.
• Synthesis of current research on cardiac immune microenvironment in sepsis.

Main Results:

• Macrophages exhibit dual roles in SCM, mediating both injury and protection.
• Mechanisms of cardiac injury include secretion of myocardial depressant substances, inflammation, mitochondrial dysfunction, and ferroptosis.
• Protective mechanisms involve anti-inflammatory responses and phagocytic repair.

Conclusions:

• Macrophage heterogeneity is critical in the pathogenesis of septic cardiomyopathy.
• Targeting specific macrophage subsets and their functions offers potential therapeutic strategies.
• Further research into the cardiac immune microenvironment is essential for effective SCM interventions.